A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E

Abstract

Production of recombinant proteins as inclusion bodies is an important strategy in the production of technical enzymes and biopharmaceutical products. So far, protein from inclusion bodies has been recovered from the cell factory through mechanical or chemical disruption methods, requiring additional cost-intensive unit operations. We describe a novel method that is using a bacteriophage-derived lysis protein to directly recover inclusion body protein from Escherichia coli from high cell density fermentation process: The recombinant inclusion body product is expressed by using a mixed feed fed-batch process which allows expression tuning via adjusting the specific uptake rate of the inducing substrate. Then, bacteriophage ΦX174-derived lysis protein E is expressed to induce cell lysis. Inclusion bodies in empty cell envelopes are harvested via centrifugation of the fermentation broth. A subsequent solubilization step reveals the recombinant protein. The process was investigated by analyzing the impact of fermentation conditions on protein E-mediated cell lysis as well as cell lysis kinetics. Optimal cell lysis efficiencies of 99% were obtained with inclusion body titers of >2.0 g/l at specific growth rates higher 0.12 h−1 and inducer uptake rates below 0.125 g/(g × h). Protein E-mediated cell disruption showed a first-order kinetics with a kinetic constant of −0.8 ± 0.3 h−1. This alternative inclusion body protein isolation technique was compared to the one via high-pressure homogenization. SDS gel analysis showed 10% less protein impurities when cells had been disrupted via high-pressure homogenization, than when empty cell envelopes including inclusion bodies were investigated. Within this contribution, an innovative technology, tuning recombinant protein production and substituting cost-intensive mechanical cell disruption, is presented. We anticipate that the presented method will simplify and reduce the production costs of inclusion body processes to produce technical enzymes and biopharmaceutical products.Electronic supplementary materialThe online version of this article (doi:10.1007/s00253-017-8281-x) contains supplementary material, which is available to authorized users.

β‐Galactosidase: From its source and applications to its recombinant form

“…The formation of inclusion bodies in E. coli imposes a great trouble in the high‐throughput production and purification of recombinant proteins 115 . Different culture conditions that influenced the formation of beta‐galactosidase inclusion bodies in E. coli were examined.…”

Enzymatic production of N-acetylneuraminic acid: advances and perspectives

“…If efficient extracellular expression is effective, the cost of enzyme expression and purification will be significantly lower than the existing cost. Effective strategies to obtain extracellular enzymes are mainly based on increasing permeability or rupturing the double membrane barrier in E. coli: use of Triton X-100 or glycine, use of cell wall free strain, and co-expression of lysis proteins [98][99][100][101]. In addition to employing these strategies for NeuAc synthesis enzymes using E. coli as a microbial cell factory, the expression of these enzymes can be optimized by selecting other hosts (such as Bacillus, Saccharomyces, Mold, and Trichoderma).…”

Secretion of recombinant proteins from E. coli

“…Alternatively, phage-derived lysis proteins can be coexpressed to induce membrane permeability [201]. Examples include the coexpression of phage X174 lysis protein E [206][207][208], MS2 lysis protein L, T4 phage lysis proteins Gpe and Gpt [209], as well as SRRz lysis operon from phage λ [210]. Depending on the lysis protein used, the cells can be either discharged, weakened (for further lysis procedures like osmotic shocks) or completely lysed resulting in lysis efficiencies of up to 99%.…”